Cryptogenic organizing pneumonia secondary prevention: Difference between revisions
No edit summary |
No edit summary |
||
Line 2: | Line 2: | ||
{{Cryptogenic organizing pneumonia}} | {{Cryptogenic organizing pneumonia}} | ||
{{CMG}}; {{AE}} {{MKK}} | |||
==Overview== | |||
Effective measures for the secondary prevention of [disease name] include [strategy 1], [strategy 2], and [strategy 3]. | |||
==Secondary Prevention== | |||
*Effective measures for the secondary prevention of [disease name] include: | |||
**[Strategy 1] | |||
**[Strategy 2] | |||
**[Strategy 3] | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Pulmonology]] | [[Category: Pulmonology]] |
Revision as of 00:38, 6 March 2018
Cryptogenic Organizing Pneumonia Microchapters |
Differentiating Cryptogenic organizing pneumonia from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Cryptogenic organizing pneumonia secondary prevention On the Web |
American Roentgen Ray Society Images of Cryptogenic organizing pneumonia secondary prevention |
FDA on Cryptogenic organizing pneumonia secondary prevention |
CDC on Cryptogenic organizing pneumonia secondary prevention |
Cryptogenic organizing pneumonia secondary prevention in the news |
Blogs on Cryptogenic organizing pneumonia secondary prevention |
Directions to Hospitals Treating Cryptogenic organizing pneumonitis |
Risk calculators and risk factors for Cryptogenic organizing pneumonia secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Manpreet Kaur, MD [2]
Overview
Effective measures for the secondary prevention of [disease name] include [strategy 1], [strategy 2], and [strategy 3].
Secondary Prevention
- Effective measures for the secondary prevention of [disease name] include:
- [Strategy 1]
- [Strategy 2]
- [Strategy 3]